Listar por autor "Martínez-Pradeda, Alejandro"
Mostrando ítems 1-5 de 5
-
Effect of gender on patients with non-small-cell lung cancer treated with immune checkpoint inhibitors: a real-world study
Calleja-Chucla, Teresa; Cordeiro González, Patricia; Martínez-Pradeda, Alejandro; Pértega-Díaz, Sonia; Margusino-Framiñán, Luis; Antolin Novoa, Silvia (MDPI, 2025-02-11)[Abstract] Objective: To evaluate the differences in overall survival (OS) and progression-free survival (PFS) between men and women with non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) ... -
Lipid profile changes associated with antiretroviral therapies in a real-world cohort
Rotea-Salvo, Sandra; Giménez-Arufe, Víctor; Martínez-Pradeda, Alejandro; Fernández Oliveira, Carla; Mena, Álvaro; Margusino-Framiñán, Luis; Martín-Herranz, Isabel; Cid-Silva, Purificación (Elsevier, 2023-06-20)[Abstract] Objective: To compare lipid profile changes and cardiovascular events among HIV naïve and experienced patients from a real-world cohort treated with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide ... -
Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward
Martínez-Pradeda, Alejandro; Albiñana Pérez, María Sandra; Fernández Oliveira, Carla; Díaz Lamas, Ana; Rey Abalo, Marta; Margusino-Framiñán, Luis; Cid-Silva, Purificación; Martín-Herranz, Isabel (Elsevier, 2023-04-18)[Abstract] Objectives: The aim of this study was to determine whether the transition of care from the intensive care unit to the ward would pose a high risk for reconciliation errors. The primary outcome of this study ... -
Observational study to compare biological drug concentration quantification techniques and immunogenicity in patients with immune-mediated diseases
Martínez-Pradeda, Alejandro; Elberdín, Laida; Porta-Sánchez, Ángeles; Outeda, María; Diz-Lois Palomares, María Teresa; Vázquez-Rey, Teresa; González-Conde, Benito; Estévez-Prieto, Emilio; Gómez-Besteiro, María I.; Martín-Herranz, Isabel (MDPI, 2024-04-10)[Abstract] Measuring biological drugs' trough concentrations and the concentrations of anti-drug antibodies is a valuable practice for treatment optimization. ELISA techniques are the gold standard for biological drug ... -
Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
Rotea-Salvo, Sandra; Martínez-Pradeda, Alejandro; Fernández-Oliveira, Carla; Giménez-Arufe, Víctor; Balboa-Barreiro, Vanesa; Margusino-Framiñán, Luis; Mena, Álvaro; Vázquez-Rodríguez, Pilar; Castro-Iglesias, Ángeles; López-Calvo, Soledad; Martín-Herranz, Isabel; Míguez-Rey, Enrique; Cid-Silva, Purificación (BMJ, 2021-10-14)[Abstract] Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (EVG/c/FTC/TAF) and dolutegravir/abacavir/lamivudine (DTG/ABC/3TC) are currently available for HIV patients. Objectives: This study evaluated ...
